EKOS Corporation, a BTG International group company

EKOS Corporation, a subsidiary of BTG International, is a medical device manufacturer based near Seattle, Washington. The company specializes in innovative interventional vascular therapies, particularly for treating severe blood clots in arteries and veins. EKOS pioneered ultrasound infusion technology in medicine, launching its first system for vascular thrombosis treatment in 2005. The flagship product, the EkoSonic® Endovascular System, is a patented device cleared for use in the US and EU markets. It utilizes ultrasound to enhance the delivery of thrombolytic drugs, improving the effectiveness of clot dissolution. This technology allows healthcare professionals, including interventional radiologists and vascular surgeons, to treat challenging clots more effectively, leading to better patient outcomes and reduced treatment times. EKOS also provides manufacturing, distribution, and support services for its medical devices globally, targeting hospitals and specialized medical centers.

• Employees 61
• Founded 1948
• Annual Revenue $94500000
• Total Funding $7921013